Walmart Replaces AstraZeneca In Nasdaq-100 Index
Nasdaq said on January 10, 2026 that Walmart will replace AstraZeneca in the Nasdaq-100, Nasdaq-100 Equal Weighted, and Nasdaq-100 Ex‑Tech Sector indexes before market open on January 20, 2026. Walmart announced in November it would shift its primary listing from the New York Stock Exchange to Nasdaq. The change alters index composition and affects funds tracking those indexes.
Scoring Rationale
Official Nasdaq announcement and direct investor impact justify score, limited by minor novelty and low AI relevance.
Practice with real FinTech & Trading data
90 SQL & Python problems · 15 industry datasets
250 free problems · No credit card
See all FinTech & Trading problems

